Gynecologic Oncology Group

Philadelphia, Pennsylvania 19103

1 studies enrolling now · 57 studies all time

What they study most

BRCA1 Mutation Carrier, BRCA2 Mutation Carrier, Breast Carcinoma, Brenner Tumor, Cervical Adenocarcinoma, Cervical Adenosquamous Carcinoma, Cervical Cancer, Cervical Intraepithelial Neoplasia Grade 3, Cervical Small Cell Carcinoma, Cervical Squamous Cell Carcinoma, Cervical Squamous Cell Carcinoma, Not Otherwise Specified, Cognitive Side Effects of Cancer Therapy

Studies at this site

• Study of Tumor Tissue Samples From Patients Who Have Undergone Surgery for Advanced Stage III or Stage IV Ovarian Epithelial Cancer — Recruiting now
• Cost of Cancer Risk Management in Women at Elevated Genetic Risk for Ovarian Cancer Who Participated on GOG-0199 — Withdrawn before enrolling
• Racial and Genetic Biomarkers of Response in Tissue Samples From Patients With Endometrial Cancer — Completed
• Biomarkers in Tumor Tissue Samples From Patients With Stage III, Stage IV, or Recurrent Endometrial Cancer — Completed
• Biomarkers in Blood and Tissue Samples From Patients With Uterine Cancer — Completed
• Biomarkers in Samples From Patients With Endometrial Cancer — Withdrawn before enrolling
• Flexitouch® Home Maintenance Therapy or Standard Home Maintenance Therapy in Treating Patients With Lower-Extremity Lymphedema Caused by Treatment for Cervical Cancer, Vulvar Cancer, or Endometrial Cancer — Stopped early
• Trastuzumab in Treating Patients With Stage III, Stage IV, or Recurrent Endometrial Cancer — Completed
• Tamoxifen Compared With Thalidomide in Treating Women With Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer — Completed
• Bortezomib in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer or Primary Peritoneal Cancer — Completed
• Imatinib Mesylate in Treating Patients With Recurrent or Persistent Uterine Cancer — Completed
• Bevacizumab in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer or Primary Peritoneal Cancer — Completed
• Ixabepilone in Treating Patients With Ovarian Epithelial or Primary Peritoneal Cancer That Has Not Responded to Previous Chemotherapy — Completed
• Bevacizumab in Treating Patients With Persistent or Recurrent Cancer of the Cervix — Completed
• Thalidomide in Treating Patients With Recurrent or Persistent Carcinosarcoma of the Uterus — Completed
• Temsirolimus in Treating Patients With Refractory or Recurrent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer — Completed
• Bevacizumab in Treating Patients With Recurrent or Persistent Endometrial Cancer — Completed
• Lapatinib in Treating Patients With Persistent or Recurrent Ovarian Epithelial or Peritoneal Cancer — Completed
• Lapatinib in Treating Patients With Recurrent or Persistent Endometrial Cancer — Completed
• Irofulven in Treating Patients With Recurrent or Persistent Ovarian Epithelial or Primary Peritoneal Cancer — Completed
• Ixabepilone in Treating Patients With Recurrent or Persistent Endometrial Cancer — Completed
• Sunitinib in Treating Patients With Recurrent or Persistent Leiomyosarcoma of the Uterus — Completed
• Gefitinib in Treating Patients With Persistent or Recurrent Endometrial Cancer — Completed
• Sorafenib in Treating Patients With Persistent or Recurrent Ovarian Epithelial or Peritoneal Cancer — Completed
• Thalidomide in Treating Patients With Recurrent or Persistent Cancer of the Uterus — Completed
• Vorinostat in Treating Patients With Recurrent or Persistent Ovarian Epithelial or Primary Peritoneal Cavity Cancer — Completed
• Paclitaxel, Bevacizumab And Adjuvant Intraperitoneal Carboplatin in Treating Patients Who Had Initial Debulking Surgery for Stage II, Stage III, or Stage IV Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer — Completed
• Carboplatin and Paclitaxel With or Without Bevacizumab Compared to Docetaxel, Carboplatin, and Paclitaxel in Treating Patients With Stage II, Stage III, or Stage IV Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity Carcinoma (Cancer) — Completed
• Combination Chemotherapy in Treating Patients With Stage III or Stage IV Ovarian Epithelial Cancer or Primary Peritoneal Cancer — Completed
• Gemcitabine and Docetaxel in Treating Patients With Recurrent or Persistent Uterine Cancer — Completed
• Comparison of Four Combination Chemotherapy Regimens Using Cisplatin in Treating Patients With Stage IVB, Recurrent, or Persistent Cancer of the Cervix — Completed
• Methotrexate Compared With Dactinomycin in Treating Patients With Gestational Trophoblastic Neoplasia — Completed
• Patient, Physician, and Nurse Factors Associated With Entry Onto Clinical Trials and Finishing Treatment in Patients With Primary or Recurrent Uterine, Endometrial, or Cervical Cancer — Completed
• Changes in Brain Function in Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer Who Are Receiving Chemotherapy — Completed
• Docetaxel in Treating Patients With Persistent or Recurrent Cervical Cancer — Completed
• Gemcitabine in Treating Patients With Recurrent or Persistent Endometrial Cancer — Completed
• Lymph Node Mapping and Sentinel Lymph Node Identification in Patients With Stage IB1 Cervical Cancer — Stopped early
• Prognostic Biomarkers in Patients With Endometrial Cancer — Completed
• Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Stage III Ovarian Cancer — Stopped early
• Oregovomab With or Without Cyclophosphamide in Treating Patients With Stage III or Stage IV Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer That Responded to Second-Line Chemotherapy — Withdrawn before enrolling
• CT-2103 in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer or Primary Peritoneal Cancer — Completed
• Breast Cancer Risk in Women Who Are BRCA1/BRCA2 Mutation Carriers — Withdrawn before enrolling
• Combination Chemotherapy and Filgrastim or Pegfilgrastim in Treating Patients With Recurrent or Persistent Cancer of the Uterus — Completed
• Medroxyprogesterone in Treating Patients With Endometrioid Adenocarcinoma of the Uterine Corpus — Completed
• Research Study in Patients With Advanced Ovarian Epithelial Cancer — Withdrawn before enrolling
• Pelvic Exenteration in Treating Patients With Recurrent Cervical Cancer — Completed
• Laparoscopic Surgery or Standard Surgery in Treating Patients With Endometrial Cancer or Cancer of the Uterus — Completed
• Comparison of Two Combination Chemotherapy Regimens Plus Radiation Therapy in Treating Patients With Stage III or Stage IV Endometrial Cancer — Completed
• Polyglutamate Paclitaxel and Carboplatin in Treating Patients With Ovarian Epithelial, Peritoneal, or Fallopian Tube Cancer — Completed
• Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Stage III or Stage IV Endometrial Cancer — Completed